連続生産と後期開発戦略：まさに今が検討の時です

連続生産と後期開発戦略：まさに今が検討の時です

連続生産は、単位オペレーションから次のぺレーションへと製品が滞りなく連続的に流れていく非常に効果的な医薬品製造方法です。現在沢山の企業が、連続生産の活用による利点と長期的なビジネスへの潜在的な影響を調査しています。こちらの資料では主に下記の点についてご説明しています。

市場投入のスピードアップ
市場の需要に対して柔軟に対応できる
製品の品質向上
錠剤あたりのコスト削減

各種資料

関連する施設紹介

San Francisco, CA

Lengnau, CH

Seneffe, Belgium

Seneffe, BE

Gosselies, Belgium

Gosselies, BE

Rheinfelden

Rheinfelden, DE

Pretoria, ZA

Pretoria, ZA

Mexico City, MX

Mexico City, MX

Vacaville, CA

Vacaville, CA

Rockville, MD

Rockville, MD

Frederick, MD

Frederick, MD

Franklin, MA

Franklin, MA

Indianapolis, IN

Indianapolis, IN

Bohemia, NY

Bohemia, NY

São Paulo, Brazil

São Paulo, BR

Santiago, Chile

Santiago, CL

Lima, Peru

Lima, PE

Bogotá, Colombia

Bogotá, CO

Weil am Rhein

Weil am Rhein, DE

Bishops Stortford, UK

Bishops Stortford, UK

Mount Prospect, Illinois

Mount Prospect, IL

Allentown, PA

Allentown, PA

Buenos Aires, Argentina

Buenos Aires, AR

Stevenage, UK

Stevenage, UK

Moscow, Russia

Moscow, RU

Horsham, UK

Horsham, UK

Basel, Switzerland

Basel, CH

Suzhou, China

Suzhou, CN (Free Trade Zone)

Tokyo, JP

Tokyo, JP

Singapore

Singapore

Incheon, Korea

Beijing, CN

Beijing, CN

Ahmedabad, IN (Domestic Tariff Area)

Ahmedabad, IN (Domestic Tariff Area)

Ahmedabad, IN (SEZ)

Ahmedabad, IN (Special Economic Zone)

Alachua, FL

Alachua, FL

Bend, OR

Bend, OR

Bourgoin, FR

Bourgoin, FR

Brisbane, AU

Brisbane, AU

Cambridge, MA

Cambridge, MA

Cincinnati, OH

Cincinnati, OH

Cork, Ireland

Cork, Ireland

Ferentino, IT

Ferentino, IT

Florence, SC (East)

Florence, SC (East)

Florence, SC (West)

Florence, SC (West)

Greenville, NC

Greenville, NC

Groningen, NL

Groningen, NL

High Point, NC

High Point, NC

Lexington, MA

Lexington, MA

Linz, AT

Linz, AT

Manatí, PR

Manatí, PR

Milton Park, UK

Milton Park, UK

Monza, IT

Monza, IT

Plainville, MA

Plainville, MA

Princeton, NJ

Princeton, NJ

Regensburg, DE

Regensburg, DE

St. Louis, MO

St. Louis, MO

Swindon, UK

Swindon, UK

Tilburg, NL

Tilburg, NL

Toronto, ON

Toronto, ON

Whitby, ON

Whitby, ON

Durham, NC

Durham, NC

Boston, MA

Boston, MA

Tokyo, JP

Tokyo, JP

関連する各種資料

Small molecule API solution: Taking a big picture approach

Manufacturing Process Scale-up for Phase III: Clear Sailing or Storms Ahead?

Process Characterization: Ready for the FDA/EU ICH guidelines

Getting from R&D to IND - Pitfalls to avoid and how to succeed

QP Release – expectations and responsibilities for clinical and commercial drug products in Europe

Fixed dose combination drug development: Designing a lifecycle strategy with agility & speed

Essential up-front planning for your clinical trial

Manufacturing Innovation: The Case for Continuous Manufacturing

Navigating Decision Points to Fast-Track Commercialisation

Building viral vector capacity and capabilities to realize the promise of gene therapies

Addressing scalability challenges in the development and manufacture of gene therapies

Quick to Care™️ program

Sterile formulation strategies to shorten timelines for first-in-human studies

Steriles Drug Development & Manufacturing: Flexibility and Optimization

Oral solid dose - Access a range of flexible drug development & manufacturing solutions

Orphan Drugs: Balancing Financial Incentives & Complex Challenges

mysupply Platform: An End-to-End Digital Supply Chain Platform

Growing Your Biopharma: Ten Questions You're Likely to Face From Investors—And How to Respond to Them

A Tale of Two CDMOs: Which Choice Will Your Biopharma Make?

Simplify Your Supply Chain in the Race to Phase 1

Navigating the Adoption of Continuous Manufacturing Amid Unprecedented Global Challenges

Impact of a Pandemic Outbreak on Vaccine Development Approach

Vaccine Development: Strategic Approach & Response During Pandemics

Analytical Considerations For Biopharmaceuticals During Commercialization

Benefits of 5KL Bioreactor When Outsourcing Late-phase Biologics Drug Substance Manufacturing

Addressing the Complexity of Process Validation for Cell and Gene Therapy products

Understanding the CMC Regulatory Landscape for Cell and Gene Therapy Products

From Patient Adherence to Manufacturing Ease - Why Softgels Make Sense for Rx

Practical Implementation of Innovative and Scalable Technologies to Accelerate Biologics Development and Commercialization: A CDMO Perspective

Evaluate Impact of Spray Drying Process Parameters and Equipment Type on the Granule Characteristic of the Immediate Release Tablets of a BCS (Biopharmaceutical Classification System) Class–IV Drug

Hot Melt Extrusion Process Optimization and Formulation Development of Amorphous Solid Dispersions for a Poorly Soluble Calcium Channel Blocker

Lyophilization: Small-Large Scale Comparability

To Determine the Dosing Disk and Encapsulation Speed for Encapsulation of a Drug Product Using Automated Encapsulator

A Quality by Design Approach to Optimize Tablet Formulations containing PVP VA64 Amorphous Dispersions: Formulation Variables

Discrete Element Modeling of a Pharmaceutical Blending Process

Accelerated stability assessment for an oral N-type calcium channel blocker

Evaluation of a Quality by Design (QbD) Approach for Process Development and Scale-Up of a Novel ALS Drug Product

Enhanced Solubilization of an Analgesic/Antipyretic Drug With The Use of Polymeric Excipients

Controlled Release of an OTC Cough Suppressant in a Soft Gelatin Based Dosage Form

Comparative PK Performance of Solution and Suspension Based Formulations For a BCS Class II Molecule in a Soft Gelatin Based Dosage Form

Development of a High Shear Wet Granulation Process Through the Use of Design of Experiments

Shortening The Timeline To First In Human (FIH) Clinical Dosage Form For Oral/Injectable Delivery

Does Your Clinical Trial Design Satisfy the Needs of your Patients

Leveraging Infrastructure Investments and Innovation to Accelerate Biologics Development

Addressing Technical Challenges in Development Drug Products: A CDMO Perspective

Total Transportation Management for the Life Science Industry Fact Sheet

Conventional vs. Unconventional Spray Drying Strategies: Development to Commercialization

Accelerating Cell Culture Development through Practical Application of Innovation Technologies

Technology Transfers Best Practices for Optimizing Success and Mitigating Risk

Leveraging Innovative Technologies, Best Practices and Strategies to Accelerate Biologics Development and Commercialization

Factoring the "What Ifs" into Supply Forecasting

Using Quality By Design For Process Development And Scale-Up Of A Novel ALS Drug Product

Transportation Solutions for Cell and Gene Therapy Supply Chains

Direct-to-Patient Pharmacy Services Overview

Depot-to-Patient Service Infographic

Quick to Care™: Integrated Drug Development and Clinical Services for New and Emerging Pharma

Sample Fulfillment & Distribution

Early Development Fact Sheet

Commercial Packaging Overview Brochure

Continuous Manufacturing: The Alternative to Batch Manufacturing

Fill / Finish Services for Viral Vectors

Infographic: A Tale of Two Molecules

Total Transportation Management Saves Company $10.2M

Ancillary Supplies: Clinical Trial "Must-Haves" that Require Early Planning

Clinical Trial Packaging: Smart Choices can Trim Timelines

Clinical Trial Packaging Solutions: Balancing Cost, Time and Quality

The Challenge of Keeping Cool: End-to-End Temperature Management for the Clinical Chain Supply

Managing Temperature Excursions

Reasons for Building an Approved Phrase Library

Taking a Strategic Approach to Comparator Drug Sourcing

What You Need to Know About Process Characterization and Validation For Biologic Processes

Telltale Signs You're with the Wrong CDMO

Driving Supply Chain Productivity in Cell Therapy Clinical Trials

Softgel Technologies Overview

Choosing the Right CDMO for Late Phase Clinical Trials

Flexibility Enables Managing Large Leaflet on Automatic Packaging Line

Biopharma Capabilities Overview

The Criticality of API CDMO Selection: Insights from a Client

Cost Savings and Speed: The Untapped Value of a Single-Source Solution

Strategies for API Solubility and Bioavailability Enhancement

Pharma Services Overview Brochure

Getting to First-in-Human Clinical Trials: A Make-or-Break Milestone for Small Biopharmas

Rise in Targeted Therapies Drives Need for Small-Volume Manufacturing

Novel Uses for Oral Solid Doses Driving Lifecycle Management Strategies

Biologics Overview: Flexible Biomanufacturing Solutions

The Economic Advantage of Single-Source Drug Development and Manufacturing

Technology Transfers: Reaping Rewards, Reducing Risks

Top Five Risks Facing Your Small Biopharma Clients Today

Multiplexing: Managing Risk with Proven, Single-Use Solutions